CD8A and focal segmental glomerulosclerosis: Given that the plasma and particularly the circulating CD8 T cells contain a high level of miR‐186‐5p following ADR treatment or under FSGS conditions, the increased miR‐186‐5p level in the kidney under disease conditions may come from activated CD8 T cells.